# Ashish Singla

> Ashish Singla is a debt financing investor at N+1 Capital backing E-Commerce and Wellness. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [N+1 Capital](https://shizune.co/investors/profile/n-1-capital)
- Total investments: 5
- Last investment: Mar 2022
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ashishsingla1/

Ashish Singla is a debt financing investor at N+1 Capital focused on E-Commerce and Wellness. Ashish Singla is the Managing Partner of N+1 Capital. He attended Northwestern University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| E-Commerce | 2 | 40% |
| Wellness | 1 | 20% |
| Logistics | 1 | 20% |
| Veterinary | 1 | 20% |
| Health Care | 1 | 20% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Debt Financing | 3 | 60% |
| Series A | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Provet Pharma | Provet Pharma Private Limited is a company that focuses on providing solutions for animal healthcare. The company is known for its innovative approach to animal health, offering a range of products and services designed to optimize the growth and wellbeing of animals. These include products that help in the maximum growth of animals, optimize milkproduction, and improve hematocrit value in weak and debilitated animals. They also offer products that aid in skin health. In addition, Provet Pharma Private Limited also provides solutions for the improvement of egg and feather quality in poultry. The company is also involved in the production of antiparasitic agents derived from the avermectins, a family of potent, broad-spectrum antiparasitic agents isolated from fermentation. |  | Venture - Series Unknown | Mar 21, 2022 |  |
| Clensta | Clensta is a biotechnology start-up to improve the National Hygiene condition whilst addressing the aspect of water conservation. Clensta is an Indian startup and in association with IIT Delhi, works to create innovative healthcare solutions to make hygiene accessible for anyone, anytime, and anywhere. Driven by their aim to create products thatpromote complete cleaning solutions without water. | $2.6M | Series A | Dec 09, 2021 |  |
| shyplite | https://shyplite.com Single dashboard for all your shipping needs. We enable E-retailers to automate their logistics and increase efficiency in shipments by providing a single window shipping platform integrated with multiple carriers. |  | Debt Financing | Jun 01, 2021 |  |
| Teamonk | Teamonk is an India's Finest Specialty Tea company. Teas and Nothing but Pure, Specialty and Premium teas. Choicest Darjeeling Teas, Nilgiris Teas, Assam Teas and Arunachal Teas that are specially curated for Teamonk. Teamonk brings you unique tea experiences, handpicked fresh from the “best tea gardens” and delivered to your doorstep. |  | Debt Financing | Jun 01, 2021 |  |
| Clensta | Clensta is a biotechnology start-up to improve the National Hygiene condition whilst addressing the aspect of water conservation. Clensta is an Indian startup and in association with IIT Delhi, works to create innovative healthcare solutions to make hygiene accessible for anyone, anytime, and anywhere. Driven by their aim to create products thatpromote complete cleaning solutions without water. | $688K | Debt Financing | May 26, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Venture Catalysts](https://shizune.co/investors/profile/venturecatalysts) — VC Fund, 2 deals together
- [HEM ANGELS](https://shizune.co/investors/profile/hem-angels) — VC Fund, 1 deal together
- [Inflection Point Ventures](https://shizune.co/investors/profile/inflection-point-ventures-d275) — VC Fund, 1 deal together
- [We Founder Circle](https://shizune.co/investors/profile/we-founder-circle) — VC Fund, 1 deal together

## About N+1 Capital

VC Fund · Delhi, India

N+1 Capital is a Revenue-based growth capital firm.

3 contacts available at N+1 Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Ajay Kumar | CFO | https://shizune.co/investors/profile/ajay-kumar-4f33 |
| Ashish Singla | Co-Founder and Managing Partner | https://shizune.co/investors/profile/ashish-singla-1764 |
| Rahul Chowdhury | Co-Founder and Managing Partner | https://shizune.co/investors/profile/rahul-chowdhury-0bec |

## Similar investors

### Similar stage
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund
- [The FSE Group](https://shizune.co/investors/profile/finance-south-east) — VC Fund

## FAQ

### What does Ashish Singla invest in?

Ashish Singla invests primarily in E-Commerce, Wellness and Logistics startups, most often at Debt Financing and Series A stage. Most of the 5 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ashish Singla last invest?

The most recent investment recorded for Ashish Singla closed in Mar 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co